Etomidate Injection Shortage: Latest Updates on Manufacturer Availability

What’s in Shortage

Etomidate Injection (Brand Name: ETOMIDATE) is currently listed in the FDA drug shortage database. This medication is primarily used within the therapeutic category of Anesthesia. The shortage was first posted on October 5, 2022, and was most recently updated on February 5, 2026.

Which Manufacturers Are Affected

While the drug remains on the shortage list, several manufacturers currently report that their presentations are available. Patients and providers should note the following status by company:

• Mylan Institutional, a Viatris Company

  • Status: Available
  • Presentations: 2 mg/1 mL (NDC 67457-902-10) and 2 mg/1 mL (NDC 67457-903-20)
  • Contact: 800-796-9526

• Caplin Steriles, Ltd. (Marketed by Fresenius Kabi)

  • Status: Available
  • Presentations: 2 mg/mL (NDC 65219-447-20), 40 mg/20 mL (NDC 65219-445-20), and 2 mg/1 mL (NDC 65219-445-10)
  • Notes: Check wholesalers for inventory.
  • Contact: 800-551-7176

• Caplin Steriles, Ltd. (Marketed by Armas Pharmaceuticals, Inc.)

  • Status: Available
  • Presentations: 2 mg/mL (NDC 72485-508-10) and 2 mg/mL (NDC 72485-509-10)
  • Notes: Check wholesalers for inventory.
  • Contact: 908-803-2586

Why There’s a Shortage

No specific reason for the shortage of Etomidate Injection was provided in the current source data.

What Patients Should Do

If you are a patient scheduled for a procedure involving anesthesia, please be aware of the following steps:

• Consult Your Healthcare Provider: Always discuss your treatment plan and any concerns regarding medication availability with your doctor or surgical team.
• Speak with a Pharmacist: Hospital pharmacists are often the first to know about local inventory levels and can provide updates on supply.
• Contact Manufacturers: If necessary, the contact numbers provided above can be used to inquire about the most recent supply status.

Disclaimer: This article is for informational purposes only. Patients should consult their healthcare provider for medical advice and treatment options.

Source

Information provided by the FDA Drug Shortage Database.